Skip to main content
SpringerLink
Log in

Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cells

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

We have previously shown that YC8, a Moloney virus-induced BALB/c lymphoma, is susceptible to lysis by BALB/c anti-DBA/2 effector cells. To further evaluate the relationship between non-H-2 antigens of DBA/2 background and tumor-associated determinants, we investigated the pattern of cytotoxic and proliferative responses induced in BALB/c mice by immunization with YC8 lymphoma. Spleen cells from tumor-immunized animals were restimulated in vitro with YC8 cells and tested for cytotoxicity on target cells of different strains and haplotypes. Cytotoxicity was observed only against YC8, DBA/2 blasts, and P815 (a DBA/2 mastocytoma). BALB/c anti-YC8 effectors were equally blocked by unlabeled YC8 and P815 cells when assayed on YC8 labeled targets. A clonal analysis, however, revealed the existence of at least two types of effectors, one lytic for both P815 and YC8 cells, the other lytic for YC8 cells only. BALB/c anti-YC8 cells proliferate when stimulated both with YC8 and DBA/2 cells in the presence of accessory cells. When tested in an adoptive transfer assay, anti-YC8 cells given i.v. cured 100% of i.v. and 75% of i. p. tumor-injected mice, respectively. When given i. p. anti-YC8 effectors cured 100% of i. p. tumor-injected animals. These results confirm the expression of non-H-2, DBA/2-like antigens on the BALB/c lymphoma YC8 and reveal the presence of additional tumor-associated determinants; both sets of antigens may induce a cellular immune response and elicit immune lymphocytes which can eradicate YC8 cells in an adoptive immunotherapy assay.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bach FH, Leshem B, Kuperman OJ, Bunzendahl H, Alter B, Zarling JM (1982) Allosensitization to obtain anti-tumor immunity. In Fefer A, Goldstein A (eds) The potential role of T cells in cancer therapy. Raven Press, New York, p 7

    Google Scholar 

  2. Biasi G, Saggin L, Dazzi F, De Rossi A, Collavo D (1983) Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus induced tumors. J Immunol 130:1447

    Google Scholar 

  3. Carter RH, Drebin JA, Schalten S, Perry LL, Greene MI (1983) Regulation of the immune response to tumor antigens. IX. In vitro Ly 1+2− cell proliferative responses to cell bound or subcellular tumor antigen. J Immunol 130:997

    Google Scholar 

  4. Colombo MP, Arioli I, Parmiani G (1984) Passive adoptive immunotherapy of low-immunogenic BALB/c lymphoma by syngeneic alloimmune T lymphocytes. Int J Cancer 34:807

    Google Scholar 

  5. Colombo MP, Parenza M, Parmiani G (1985) Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: Characterization of the effector population and evidence for the role of the host's non-T cells. Cancer Immunol Immunother 20:198

    Google Scholar 

  6. Fernandez-Cruz E, Woda BA, Feldman JD (1980) Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes. J Exp Med 152:823

    Google Scholar 

  7. Festenstein H (1976) The Mls system. Transplant Proc 8:339

    Google Scholar 

  8. Fossati G, Balsari A, Taramelli D, Sensi ML, Pellegris G, Nava M, Parmiani G (1982) Lysis of human melanoma cells by in vitro allosensitized peripheral blood lymphocytes. Cancer Immunol Immunother 14:99

    Google Scholar 

  9. Gomard E, Levy JP, Plata F, Henin Y, Duprez V, Bismuth A, Reme T (1978) Studies on the nature of cell surface antigens reacting with cytolytic T lymphocytes in murine oncornavirus-induced tumors. Eur J Immunol 8:228

    Google Scholar 

  10. Greenberg PD, Cheever MA (1984) Treatment of disseminated leukemia with cyclophosphamide and immune cells; Tumor immunity reflects long term persistance of tumor-specific donor T cells. J Immunol 133:3401

    Google Scholar 

  11. Greenberg PD, Kern DE, Cheever MA (1985) Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt 1+2− T cells. Tumor eradication does not require participation of cytotoxic T cells. J Exp Med 161:1122

    Google Scholar 

  12. Grimm EA, Mazumder A, Zhang Z, Rosenberg SA (1982) Lymphokine activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumour cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J Exp Med 155:1823

    Article  CAS  PubMed  Google Scholar 

  13. Leshem B, Gotsman B, Kedar E (1984) In vitro elicitation of cytotoxic response against a non-immunogenic murine tumor by allosensitization. Cancer Immunol Immunother 17:117

    Google Scholar 

  14. Paciucci PA, Mac Phail S, Zarling JM, Bach FH (1980) Lysis of syngeneic solid tumor by alloantigen stimulated mouse T and non-T cells. J Immunol 124:370

    Google Scholar 

  15. Parmiani G, Sensi ML, Carbone G, Colombo MP, Pierotti MA, Ballinari D, Hilgers J, Hilkens J (1982) Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice. Int J Cancer 29:323

    Google Scholar 

  16. Parmiani G, Sensi ML, Fossati G (1985) Allostimulation induced tumor cytotoxic cells: from mouse to man. Immunol Today 6:215

    Google Scholar 

  17. Pierotti MA, Parmiani G (1984) Alien antigens on tumor cells revisited. J Immunogenet 11:1

    Google Scholar 

  18. Russel JH, Ginns LC, Terres G, Eisen HN (1979) Tumor antigens as inappropriately expressed normal alloantigens. J Immunol 122:912

    Google Scholar 

  19. Ryser JE, Cerottini JC, Brunner KT (1978) Generation of cytolytic T lymphocytes in vitro. X. Induction of secondary CTL response in primary long term MLC by supernatants from secondary MLC. J Immunol 120:370

    Google Scholar 

  20. Sensi ML, Carbone G, Parmiani G (1980) Original H-2d and alien H-2k like antigens of a BALB/c fibrosarcoma as defined by in vitro and in vivo studies of cell-mediated immunity. Eur J Immunol 10:671

    Google Scholar 

  21. Sensi ML, Parenza M, Parmiani G (1983) Alloreactivity and tumor antigens: generation of syngeneic anti-lymphoma killer lymphocytes by alloimmunization of mice with normal cells. J Natl Cancer Inst 70:291

    Google Scholar 

  22. Sensi ML, Orosz CG, Bach FH (1984) Alloantigen-induced cytotoxicity against tumor cells; analysis at the clonal level. J Immunol 132:3218

    Google Scholar 

  23. Strausser JL, Mazumder A, Grimm EA, Lotze MT, Rosenberg SA (1981) Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens. J Immunol 127:266

    Google Scholar 

  24. Vose BM, White W (1983) Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Clonal analysis of effector cells in cytotoxic and proliferative assay. Cancer Immunol Immunother 15:227

    Google Scholar 

  25. Widmer MB, Bach FH (1981) Antigen driven helper cell independent cloned cytolytic T lymphocytes. Nature 294:750

    Google Scholar 

  26. Widmer MB, Bach FH (1983) Antigen specificity and helper characteristics of antigen-driven helper-cell independent cytolytic T lymphocytes. Transplantation 36:565

    Google Scholar 

  27. Wortzel RD, Philipps C, Schreiber H (1983) Multiple tumour-specific antigens expressed on a single tumour cell. Nature 304:165

    Google Scholar 

  28. Zagury D, Bernard J, Thiernesse N, Feldman M, Berke G (1975) Isolation and characterization of individual functionally reactive cytotoxic T lymphocytes; conjugation, killing and recycling at the single cell level. Eur J Immunol 5:618

    Google Scholar 

  29. Zarling JM, Robins HI, Raich PC, Bach FH, Bach ML (1978) Generation of cytotoxic T lymphocytes to autologous human leukemia cells by sensitization to pooled allogeneic normal cells. Nature 274:269

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Experimental Oncology D, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, I-20133, Milan, Italy

    Marialuisa Sensi, Laura Grazioli & Giorgio Parmiani

Authors
  1. Marialuisa Sensi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Grazioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giorgio Parmiani
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sensi, M., Grazioli, L. & Parmiani, G. Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cells. Cancer Immunol Immunother 21, 199–204 (1986). https://doi.org/10.1007/BF00199362

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199362

Keywords

Search

Navigation